UNSPSC 51282802: Coumamycin

This classification denotes an antibiotic with the molecular formula C55H59N5O20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, PCH9QZ1IIH chemically known as 5-methylpyyrole-2-carboxylic acid, diester with 3,3'-((3-methylpyrrole-2,4-diyl)bis(carbonylimino))bis(4-hydroxy-8-methyl-7-((tetrahydro-3,4-dihydroxy-5-methoxy-6,6-dimethylpyran-2-yl)oxy)coumarin) but generally known as coumamycin, which bears US NIH Compound Identifier 20494.

UNSPSC 51282802 Coumamycin is a Commodity code that encompasses pharmaceutical products and related medical supplies procured by state and local health agencies. Recent state and local activity under this code shows procurement of antibiotics, opioid-reversal agents, and drug-management systems rather than coumamycin specifically. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a 12-month initial term and renewal options for years 2 and 3. Seminole County, Florida issued an IFB on June 30, 2026, for the annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. State health departments and county health agencies are the primary issuing bodies active under this code, procuring through cooperative purchasing vehicles and competitive bidding processes.

Geographic activity centers on Illinois and Florida based on recent opportunities. The Illinois procurement leverages a multi-state cooperative consortium (MMCAP Infuse), while the Seminole County award operates independently. Both solicitations impose standard compliance requirements including drug-free workplace certification, E-Verify eligibility verification, and applicable insurance coverage. No set-aside designations or vendor preferences are evident in the recent awards. Delivery and fulfillment logistics are specified at the point of use, with vendors absorbing shipping costs into pricing.